Pavel Fabian
Overview
Explore the profile of Pavel Fabian including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
74
Citations
730
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pavlickova K, Hojny J, Waldauf P, Dundr P, Hajkova N, Svajdler M, et al.
Virchows Arch
. 2025 Jan;
PMID: 39843568
Extrapulmonary small cell neuroendocrine carcinoma (EP-SCNC) is a rare malignancy with a poor prognosis. Despite its morphological similarity to lung small cell carcinomas, its oncogenesis remains uncertain. One hundred and...
2.
Pavlickova K, Hojny J, Waldauf P, Svajdler M, Dundr P, Fabian P, et al.
Lab Invest
. 2025 Jan;
105(4):104093.
PMID: 39826683
Extrapulmonary small cell neuroendocrine carcinoma (EP-SCNC) is a rare malignancy with a poor prognosis. Most patients with EP-SCNC have metastatic disease upon presentation, and their average overall survival (OS) is...
3.
Nemejcova K, Safanda A, Kendall Bartu M, Hajkova N, Drozenova J, Fabian P, et al.
Int J Gynecol Pathol
. 2024 Sep;
PMID: 39230502
Using immunohistochemistry, we examined a large cohort of 135 ovarian tumors, made up of 96 low-grade serous carcinomas (LGSCs) and 39 serous borderline tumors (micropapillary variant, mSBT), with the aim...
4.
Prochazkova J, Fedr R, Hradilova B, Kvokackova B, Slavik J, Kovac O, et al.
J Lipid Res
. 2024 Jul;
65(9):100609.
PMID: 39084491
Glycosylated sphingolipids (GSLs) are a diverse group of cellular lipids typically reported as being rare in normal mammary tissue. In breast cancer (BCa), GSLs have emerged as noteworthy markers associated...
5.
Gkekas I, Jan N, Kaprio T, Beilmann-Lehtonen I, Fabian P, Tavelin B, et al.
J Surg Oncol
. 2024 Mar;
129(7):1295-1304.
PMID: 38470492
Background And Objectives: Disparities between tumors arising via different sporadic carcinogenetic pathways have not been studied systematically. This retrospective multicenter cohort study evaluated the differences in the risk for non-colorectal...
6.
Struzinska I, Hajkova N, Hojny J, Krkavcova E, Michalkova R, Bui Q, et al.
J Mol Diagn
. 2024 Jan;
26(4):257-266.
PMID: 38280423
Low-grade serous carcinoma (LGSC) may develop from serous borderline tumor (SBT) tissue, where the micropapillary type (mSBT) presents the highest risk for progression. The sensitivity of LGSC to standard chemotherapy...
7.
Zatecky J, Coufal O, Fabian P, Holanek M, Sehnalkova E, Burkon P
Breast Care (Basel)
. 2023 Oct;
18(4):262-269.
PMID: 37900556
Introduction: Primary breast sarcoma is a very rare malignant type of breast tumours with an incidence of 0.1% of all primary breast malignancies. Methods: We present a retrospective analysis of...
8.
Kendall Bartu M, Nemejcova K, Michalkova R, Struzinska I, Hajkova N, Hojny J, et al.
Virchows Arch
. 2023 Sep;
483(4):497-507.
PMID: 37676270
Ovarian clear cell carcinoma (OCCC) is a subtype of ovarian carcinoma characterized by unique biological features and highly malignant characteristics including low chemosensitivity. Therefore, new therapeutic targets are needed. These...
9.
Safanda A, Kendall Bartu M, Michalkova R, Struzinska I, Drozenova J, Fabian P, et al.
Virchows Arch
. 2023 Aug;
483(4):509-516.
PMID: 37610627
Preferentially expressed antigen of melanoma (PRAME) is a cancer/testis antigen selectively expressed in somatic tissues and various solid malignant tumors and is associated with poor prognostic outcome. Our research aimed...
10.
Dundr P, Hajkova N, Kendall Bartu M, Cibula D, Drozenova J, Fabian P, et al.
Pathology
. 2023 Jul;
55(6):785-791.
PMID: 37500307
In gynecological neoplasms, immunohistochemical (IHC) expression of p53 is generally an accurate predictor of TP53 mutation status if correctly interpreted by the pathologist. However, the literature concerning cut-offs, frequency and...